Navigation Links
Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays

Agilent Technologies Inc. (NYSE: A) today announced that it has for the first time released the chip design, probe sequence and annotation information for all of its microarrays. The release of this information is expected to improve cross-laboratory experimental research and cross-platform data comparison.

"Full release of the probe sequences is an admirable and responsible position for Agilent to take," said Catherine Ball, president of the Microarray Gene Expression Data (MGED) Society and director of the Stanford Microarray Database. "Rigorous science requires that others be able to easily interpret and verify or contradict one's work. With this sequence information, the research community will be better equipped to interpret data generated with Agilent arrays and to determine confidence in these data in future years, when genomic sequences may have been updated. In that sense, release of these sequences makes the results of experiments using Agilent arrays far more valuable."

This announcement is being made in conjunction with the extensive release of microarray experimental data into the public domain by the National Toxicology Program. Icoria Inc., under its contract with the National Institute of Environmental Health Sciences (NIEHS), has been using Agilent microarrays to perform thousands of experiments to profile chemical effects on biological systems, thereby creating a vast resource of gene expression responses to chemical toxicants. The data will eventually be made available through the NIEHS National Center of Toxicogenomics' Chemical Effects on Biological Systems (CEBS) database, currently under development.

"The NIEHS National Center for Toxicogenomics is very pleased that Agilent has released the probe sequences for its gene expression microarrays to the public domain," said Michael Waters, Ph.D., assistant director for database development of the NCT. "The availability of these sequences will be of great benefit to the microa rray bioinformatics community and to databases such as the NCT's CEBS as we seek to make high-quality toxicogenomics data sets publicly available."

The microarray design and probe sequence information is now available on Agilent's eArray web portal at earray.chem.agilent.com. On the same site, customers can examine the content of Agilent-manufactured commercial microarrays and design their own custom microarrays. Agilent-manufactured microarrays are based on the industry-standard 1" x 3" slide format, making them readily and easily accessible to any researchers who want to achieve a high degree of sensitivity and precision in their experiments.


'"/>

Source:Agilent


Related biology news :

1. Agilent Technologies releases automated literature search tool for biology researchers
2. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
3. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
4. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
5. Agilent Technologies introduces high-capacity human protein removal system for proteomics research
6. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
7. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
8. Center releases new public survey on stem cells
9. DOE JGI releases IMG 1.5 with curated archaeal genomes
10. DOE JGI sequences, releases genome of symbiotic tree fungus
11. Triple threat polymer captures and releases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2019)... ... December 01, 2019 , ... Each year ... and techniques to hit the life-science landscape. For more than a decade, our ... in laboratories and facilitating biological discovery. This year’s crop of entries to The ...
(Date:11/27/2019)... ... November 26, 2019 , ... Personalized Stem Cells, Inc ... by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero ... place on October 23, 2019, highlighted the ongoing efforts to promote research, educate the ...
(Date:11/20/2019)... (PRWEB) , ... November 20, 2019 , ... BioInformatics Inc., ... life science tools market, today announced the winners of the Life Science Industry Awards ... of the Life Science Industry Awards – Innovation: , Most Innovative New Product – ...
Breaking Biology News(10 mins):
(Date:1/7/2020)... ... January 07, 2020 , ... ... and services, today announced the launch of its VivopureX™ recombinant mouse antibodies for ... many originally obtained from rats or hamsters, which Absolute Antibody has engineered into ...
(Date:12/31/2019)... ... December 31, 2019 , ... Vici Health ... development lab in Maryland. Emphasis will be in expanding capabilities in both ... Health Sciences will be well positioned to meet the growing demand for its ...
(Date:12/23/2019)... ... December 23, 2019 , ... Leak Detection Associates, the leading ... Medical Device Industries, is excited to announce that it will be a contributing ... Closure Integrity Testing Basic Training Course . Held in conjunction with PDA Europe’s ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... Medcure, Inc. has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy ... clinical data suggests the CAPERE® offers great benefits for first-in-line treatment for ...
Breaking Biology Technology: